相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
Waleed H. Mahallawi et al.
CYTOKINE (2018)
MERS-CoV 4b protein interferes with the NF-kappa B-dependent innate immune response during infection
Javier Canton et al.
PLOS PATHOGENS (2018)
Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ
Ahmed A. Al-Qahtani et al.
ONCOTARGET (2017)
Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection
Victor M. Corman et al.
CLINICAL INFECTIOUS DISEASES (2016)
Discovery of T-Cell Infection and Apoptosis by Middle East Respiratory Syndrome Coronavirus
Tianlei Ying et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
Hin Chu et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012-2015
Abdullah J. Alsahafi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
Antibody Response and Disease Severity in Healthcare Worker MERS Survivors
Abeer N. Alshukairi et al.
EMERGING INFECTIOUS DISEASES (2016)
Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia
Abdullah Assiri et al.
EMERGING INFECTIOUS DISEASES (2016)
Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus
Daniel C. Payne et al.
EMERGING INFECTIOUS DISEASES (2016)
Time Course of MERS-CoV Infection and Immunity in Dromedary Camels
Benjamin Meyer et al.
EMERGING INFECTIOUS DISEASES (2016)
Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
Jasper F. W. Chan et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
Xiaojuan Guo et al.
IMMUNOLOGY (2015)
Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
Asisa Volz et al.
JOURNAL OF VIROLOGY (2015)
Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease
Anurodh Shankar Agrawal et al.
JOURNAL OF VIROLOGY (2015)
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
Kristen E. Pascal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis
Jie Zhou et al.
VIROLOGY JOURNAL (2015)
Receptor-binding domain-based subunit vaccines against MERS-CoV
Naru Zhang et al.
VIRUS RESEARCH (2015)
Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
Allison L. Totura et al.
MBIO (2015)
Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
Jian Tang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea
Wan Beom Park et al.
EMERGING INFECTIOUS DISEASES (2015)
Current advancements and potential strategies in the development of MERS-CoV vaccines
Naru Zhang et al.
EXPERT REVIEW OF VACCINES (2014)
T cell-mediated immune response to respiratory coronaviruses
Rudragouda Channappanavar et al.
IMMUNOLOGIC RESEARCH (2014)
Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
Brit J. Hart et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
Jie Zhou et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Middle East Respiratory Syndrome Coronavirus 4a Protein Is a Double-Stranded RNA-Binding Protein That Suppresses PACT-Induced Activation of RIG-I and MDA5 in the Innate Antiviral Response
Kam-Leung Siu et al.
JOURNAL OF VIROLOGY (2014)
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
Joost H. C. M. Kreijtz et al.
LANCET INFECTIOUS DISEASES (2014)
Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
Emmanuel Faure et al.
PLOS ONE (2014)
Rapid generation of a mouse model for Middle East respiratory syndrome
Jincun Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments-The importance of immunofocusing in subunit vaccine design
Cuiqing Ma et al.
VACCINE (2014)
Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
Cuiqing Ma et al.
VACCINE (2014)
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
Christopher M. Coleman et al.
VACCINE (2014)
Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response
Hin Chu et al.
VIROLOGY (2014)
Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
Shuai Xia et al.
VIRUS RESEARCH (2014)
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
Arwen F. Altenburg et al.
VIRUSES-BASEL (2014)
Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia
Abdulaziz N. Alagaili et al.
MBIO (2014)
A tale of two cytokines: IL-17 and IL-22 in asthma and infection
Michelle L. Manni et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2014)
Antibodies against MERS Coronavirus in Dromedary Camels, Kenya, 1992-2013
Victor M. Corman et al.
EMERGING INFECTIOUS DISEASES (2014)
Human Infection with MERS Coronavirus after Exposure to Infected Camels, Saudi Arabia, 2013
Ziad A. Memish et al.
EMERGING INFECTIOUS DISEASES (2014)
Replicative Capacity of MERS Coronavirus in Livestock Cell Lines
Isabella Eckerle et al.
EMERGING INFECTIOUS DISEASES (2014)
MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment
Adriaan H. de Wilde et al.
JOURNAL OF GENERAL VIROLOGY (2013)
Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC
Lanying Du et al.
JOURNAL OF INFECTION (2013)
Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
Kwok-Hung Chan et al.
JOURNAL OF INFECTION (2013)
Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies
Fei Song et al.
JOURNAL OF VIROLOGY (2013)
The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
Huihui Mou et al.
JOURNAL OF VIROLOGY (2013)
Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures
Renee W. Y. Chan et al.
JOURNAL OF VIROLOGY (2013)
Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
Lanying Du et al.
JOURNAL OF VIROLOGY (2013)
Human Cell Tropism and Innate Immune System Interactions of Human Respiratory Coronavirus EMC Compared to Those of Severe Acute Respiratory Syndrome Coronavirus
Florian Zielecki et al.
JOURNAL OF VIROLOGY (2013)
Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist
Daniela Niemeyer et al.
JOURNAL OF VIROLOGY (2013)
Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study
Matthew Cotten et al.
LANCET (2013)
Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
Romulus Breban et al.
LANCET (2013)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
Lanying Du et al.
PLOS ONE (2013)
NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections
Raymond M. Welsh et al.
VIROLOGY (2013)
Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
Laurence Josset et al.
MBIO (2013)
The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists
Yang Yang et al.
PROTEIN & CELL (2013)
IL-17 cytokines in immunity and inflammation
Wei Jin et al.
EMERGING MICROBES & INFECTIONS (2013)
Dendritic cells: a spot on sialic acid
Helio J. Crespo et al.
FRONTIERS IN IMMUNOLOGY (2013)
Negative regulatory approaches to the attenuation of Toll-like receptor signaling
Muhammad Ayaz Anwar et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia
Ziad A. Memish et al.
EMERGING INFECTIOUS DISEASES (2013)
Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome
Shibo Jiang et al.
EXPERT REVIEW OF VACCINES (2012)
Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo
Qiuwei Pan et al.
HEPATOLOGY (2012)
Clusters of coronavirus cases put scientists on alert
Declan Butler
NATURE (2012)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation
Karin Lovgren Bengtsson et al.
EXPERT REVIEW OF VACCINES (2011)
RIG-I-like receptors: cytoplasmic sensors for non-self RNA
Hiroki Kato et al.
IMMUNOLOGICAL REVIEWS (2011)
TLR-signaling Networks: An Integration of Adaptor Molecules, Kinases, and Cross-talk
J. Brown et al.
JOURNAL OF DENTAL RESEARCH (2011)
Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
Fang Tang et al.
JOURNAL OF IMMUNOLOGY (2011)
Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
Ye V. Liu et al.
VACCINE (2011)
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial
Rebecca J. Cox et al.
VACCINE (2011)
IL-10 family of cytokines
Robert Sabat
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Toll-like receptors and innate immunity
Himanshu Kumar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Effect of Preexisting Immunity on an Adenovirus Vaccine Vector: In Vitro Neutralization Assays Fail To Predict Inhibition by Antiviral Antibody In Vivo
Susan L. Pichla-Gollon et al.
JOURNAL OF VIROLOGY (2009)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection
Lanying Du et al.
JOURNAL OF IMMUNOLOGY (2008)
MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
Timothy Sheahan et al.
PLOS PATHOGENS (2008)
Toll-like receptor signal transduction
Jayalakshmi Krishnan et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome
Mark J. Cameron et al.
JOURNAL OF VIROLOGY (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
Lanying Du et al.
VACCINE (2007)
IL-10, T cell exhaustion and viral persistence
Shawn D. Blackburn et al.
TRENDS IN MICROBIOLOGY (2007)
Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome
W Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors
Kenya Honda et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies
YX He et al.
JOURNAL OF IMMUNOLOGY (2005)
Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region
ZW Chen et al.
JOURNAL OF VIROLOGY (2005)
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
H Bisht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
ZY Yang et al.
NATURE (2004)
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
M Yoneyama et al.
NATURE IMMUNOLOGY (2004)
Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets
H Weingartl et al.
JOURNAL OF VIROLOGY (2004)
A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice
N Takasuka et al.
INTERNATIONAL IMMUNOLOGY (2004)
Effects of a SARS-associated coronavirus vaccine in monkeys
WT Gao et al.
LANCET (2003)
Lung pathology of fatal severe acute respiratory syndrome
JM Nicholls et al.
LANCET (2003)
CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO
T Ishii et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A weak signal for strong responses:: Interferon-α/β revisited
T Taniguchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Studies on the supply of immunoglobulin G to newborn camel calves (Camelus dromedarius)
R Kamber et al.
JOURNAL OF DAIRY RESEARCH (2001)
Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection
S Balachandran et al.
IMMUNITY (2000)
分享论文
